After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Biodexa Pharmaceuticals Plc (BDRX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.11, or 1.92%, to $5.84. The Biodexa Pharmaceuticals Plc has recorded 11,151 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Stocks Info
Biodexa Pharmaceuticals Plc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $5.73 and fluctuated between $6.53 as its day high and $5.50 as its day low. The current market capitalization of Biodexa Pharmaceuticals Plc is $4.35M. A total of 0.51 million shares were traded on the day, compared to an average of 624.76K shares.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for BDRX in the last 3 months, the mean price target is $251,959.00 with high estimates of $251,959.00 and low estimates of $251,959.00. In terms of 52-week highs and lows, BDRX has a high of $1664.00 and a low of $3.51.
As of this writing, BDRX has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BDRX’s latest balance sheet shows that the firm has $10.06M in Cash & Short Term Investments as of fiscal 2021. There were $766.00k in debt and $1.84M in liabilities at the time. Its Book Value Per Share was $20036.01, while its Total Shareholder’s Equity was $10.45M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
